Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovix (ENVX) Cash & Equivalents (2020 - 2025)

Enovix (ENVX) has disclosed Cash & Equivalents for 6 consecutive years, with $106.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 61.15% year-over-year to $106.0 million, compared with a TTM value of $106.0 million through Dec 2025, down 61.15%, and an annual FY2025 reading of $106.0 million, down 61.15% over the prior year.
  • Cash & Equivalents was $106.0 million for Q4 2025 at Enovix, down from $335.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $408.2 million in Q2 2022 and bottomed at $5.0 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $255.6 million, with a median of $272.9 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents skyrocketed 7670.75% in 2022, then tumbled 61.15% in 2025.
  • Year by year, Cash & Equivalents stood at $338.7 million in 2021, then rose by 3.03% to $349.0 million in 2022, then tumbled by 33.2% to $233.1 million in 2023, then increased by 17.06% to $272.9 million in 2024, then tumbled by 61.15% to $106.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for ENVX at $106.0 million in Q4 2025, $335.5 million in Q3 2025, and $136.0 million in Q2 2025.